CN102727806B - Traditional Chinese medicine for treating aplastic anemia by tonifying qi - Google Patents
Traditional Chinese medicine for treating aplastic anemia by tonifying qi Download PDFInfo
- Publication number
- CN102727806B CN102727806B CN201210176180XA CN201210176180A CN102727806B CN 102727806 B CN102727806 B CN 102727806B CN 201210176180X A CN201210176180X A CN 201210176180XA CN 201210176180 A CN201210176180 A CN 201210176180A CN 102727806 B CN102727806 B CN 102727806B
- Authority
- CN
- China
- Prior art keywords
- medicine
- aplastic anemia
- chinese medicine
- tonifying
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating aplastic anemia by tonifying qi. Raw materials for the medicine comprise, by weight, 25 to 30 of plant soot, 25 to 30 of furnace oil, 25 to 30 of Psoralea corylifolia, 25 to 30 of black alum, 30 to 35 of walnut pulp, 30 to 35 of red date, 30 to 35 of honey, 8 to 10 of cassia bark, 25 to 30 of dust-doped flour obtained during flour grinding, 3 to 5 of charred human hair, 10 to 12 of ginseng, 10 to 12 of Chinese angelica, 10 to 12 of prepared fleece flower root, 10 to 12 ofbighead atractylodes rhizome, 18 to 20 of mantis egg-case, 18 to 20 of sharpleaf galangal fruit and 18 to 20 of Dioscorea opposite Thunb. A formula for the medicine provided in the invention is simple and practicable; preparation of the medicine is convenient; and the medicine can nourish qi and yin and strengthen essence and marrow and has a high cure rate and a good curative effect when used for treating aplastic anemia by tonifying qi.
Description
Technical field:
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of Chinese medicine for QI invigorating treatment aplastic anemia.
Background technology:
Aplastic anemia is because hemopoietic function of bone marrow goes down or exhaustion, the syndrome that hemocyte is grown and all reduced and cause.Primary disease is in the majority with person between twenty and fifty.Chronic aplastic anemia such as timely diagnosis and treatment, prognosis is fair.Aplastic anemia belongs to the categories such as the traditional Chinese medical science " asthenia ", " mass formed by blood stasis ".Main manifestations is Anemia, hemorrhage and infect, heating is slighter.
Comparatively difficulty is not illustrated, treats yet to Western medicine fully to its cause of disease, and traditional therapy needs periodic transfusions, transfusion and hospitalization, and cure rate is low, and financial burden heavily waits to patient and family members and brought misery and lost the confidence for the treatment of.And the drug price that is used for the treatment of at present aplastic anemia is expensive, medical expense is high, therapeutic effect is undesirable.
Summary of the invention:
The object of the invention is exactly in order to make up the defect of prior art, and a kind of Chinese medicine of air-supplementing method treatment aplastic anemia is provided, and it has eutherapeutic advantage.
The present invention is achieved by the following technical solutions:
A kind of Chinese medicine for QI invigorating treatment aplastic anemia, it is characterized in that: the weight proportion of each raw material components is: Pulvis Fumi Carbonisatus 25-30, Terra Flava Usta 25-30, Fructus Psoraleae 25-30, ?vitriol 25-30, Semen Juglandis 30-35, Fructus Jujubae 30-35, Mel 30-35, Cortex Cinnamomi 1-10, Semen Tritici aestivi 25-30, Crinis Carbonisatus 1-5, Radix Ginseng 10-20, Radix Angelicae Sinensis 10-12, Radix Polygoni Multiflori Preparata 10-12, Rhizoma Atractylodis Macrocephalae 10-12, Ootheca Mantidis 18-20, Fructus Alpiniae Oxyphyllae 18-20, Rhizoma dioscoreae 18-20.
The Chinese medicine of a kind of QI invigorating treatment aplastic anemia, it is characterized in that: the weight proportion of each raw material components is: Pulvis Fumi Carbonisatus 30, Terra Flava Usta 30, Fructus Psoraleae 30, ?vitriol 30, Semen Juglandis 40, Fructus Jujubae 40, Mel 40, Cortex Cinnamomi 5, Semen Tritici aestivi 30, Crinis Carbonisatus 3, Radix Ginseng 15, Radix Angelicae Sinensis 10, Radix Polygoni Multiflori Preparata 10, the Rhizoma Atractylodis Macrocephalae 10, Ootheca Mantidis 20, Fructus Alpiniae Oxyphyllae 20, Rhizoma dioscoreae 20.
Every dose of medicine 150g of medicine of the present invention, add water and boil decoction and take, every day potion, potion is taken at twice.
Advantage of the present invention is:
The present invention's outstanding Radix Ginseng strongly invigorating primordial QI of filling a prescription, vigour fill that each function is active, give full play to the health autoimmune function and regulate, and treatment aplastic anemia cure rate is high, good effect.
The specific embodiment:
A kind of Chinese medicine for QI invigorating treatment aplastic anemia, the weight of each raw material components (gram) is: Pulvis Fumi Carbonisatus 30, Terra Flava Usta 30, Fructus Psoraleae 30, ?vitriol 30, Semen Juglandis 35, Fructus Jujubae 35, Mel 35, Cortex Cinnamomi 8, Semen Tritici aestivi 30, Crinis Carbonisatus 3, Radix Ginseng 10, Radix Angelicae Sinensis 10, Radix Polygoni Multiflori Preparata 10, the Rhizoma Atractylodis Macrocephalae 10, Ootheca Mantidis 20, Fructus Alpiniae Oxyphyllae 20, Rhizoma dioscoreae 20.
By above-mentioned Chinese medicine formula preparation Chinese medicine, between every pair of Chinese medicine 150-180 gram, be decocted in water for oral dose one pair every day, a minute secondary is taken.
Case:
1, aplastic anemia patient king * *, the male, 52 years old, main cause was interrupted weak 3 years, increased the weight of 1 month, the cough heat that occurs together, breathe hard after activity, the routine of having a blood test: WBC:4.1 * 109/L HB:73g/L PLT:10 * 109/L, body temperature is the highest 38 °, take medicine decoction of the present invention, after the week, patient's body temperature is normal, and after January, patient's routine of having a blood test is shown: platelet and hemoglobin are more steady.After two months, the patient checks routine blood test and shows: HB:112g/L, existing conditions of patients is slightly steady, continues present Regimen Chemotherapy.
2, journey *, the female, 31 years old, the appearance epistaxis of the obvious inducement of nothing before 3 months, and be difficult for stopping, be interrupted heating, the routine of having a blood test is shown: WBC 2.5 * 10
9/ L, HB 68g/L, PLT 9 * 10
9/ L, look into bone and wear and show: Hypolasia, grain are that red system reduces, megalokaryocyte lack as, be diagnosed as acute aplastic anemia.Give ciclosporin in treating, and be interrupted blood transfusion and platelet transfusion support, associating anti-infective therapy, the state of an illness is without being clearly better.
The patient upon somebody's introduction, takes medicine of the present invention, simultaneously the platelet transfusion support, the patient is without heating, and cough takes a turn for the better, and after three months, breaks away from platelet transfusion and blood transfusion, the medication treatment that holds on, patient's hemogram three is all to recover normal after treatment half a year, continues drug oral after treatment of the present invention.
3, summer * *, 21 years old, the patient cough, watery nasal discharge occurred without obvious inducement at the beginning of 2008 3 months, with pallor, go to a doctor in local hospital, the routine of having a blood test is shown: WBC 5.9 * 10
9/ L, HB63g/L, PLT550 * 10
9/ L, be diagnosed as " pure red cell aplasia ", the Supporting Therapy of being transfused blood, and application " the third ball " treatment, and conditions of patients is without being clearly better.Upon somebody's introduction, take medicine of the present invention, simultaneously, after 1 week, patient's hemogram slightly has rising, continues and takes medicine 2 months, and hemogram obviously rises, and after 3 months, patient's hemogram is normal, and rear patient consolidates again remaining drug withdrawal half a year, and patient's hemogram is normal so far, without uncomfortable symptom.
4, the outstanding * * of patient, the male, 22 years old, the patient without obviously the inducement appearance is dizzy, weak, without heating, without discomforts such as cough, expectorations, went to a doctor in local hospital before more than 1 year, and the routine of having a blood test and bone marrow aspiration, be diagnosed as " chronic aplastic anemia ".Gave the ciclosporin A capsule oral 3 months, and be interrupted blood transfusion Supporting Therapy, the state of an illness is without being clearly better, the routine of having a blood test, and WBC 1.32 * 10
9/ L HB 24g/L PLT11 * 10
9/ L Rc 0.7%.Take Chinese medicine of the present invention, and be interrupted blood transfusion Supporting Therapy, after January, the patient breaks away from blood transfusion, and after 2 months, hemogram raises obviously, and the patient continued to take more than Chinese medicine of the present invention half a year, and the check routine blood test shows: WBC 3.74 * 10
9/ L HB 112g/L PLT32 * 10
9/ L.Now still take Chinese medicine after treatment of the present invention.In order.
Claims (1)
1. the Chinese medicine of QI invigorating treatment aplastic anemia, it is characterized in that: the weight proportion of each raw material components is: Pulvis Fumi Carbonisatus 25-30, Terra Flava Usta 25-30, Fructus Psoraleae 25-30, Alumen preparata 25-30, Semen Juglandis 30-35, Fructus Jujubae 30-35, Mel 30-35, Cortex Cinnamomi 8-10, Semen Tritici aestivi 25-30, Crinis Carbonisatus 3-5, Radix Ginseng 10-12, Radix Angelicae Sinensis 10-20, Radix Polygoni Multiflori Preparata 10-12, Rhizoma Atractylodis Macrocephalae 10-12, Ootheca Mantidis 18-20, Fructus Alpiniae Oxyphyllae 18-20, Rhizoma dioscoreae 18-20.
2, the Chinese medicine of QI invigorating treatment aplastic anemia according to claim 1, it is characterized in that: the weight proportion of each raw material components is: Pulvis Fumi Carbonisatus 30, Terra Flava Usta 30, Fructus Psoraleae 30, Alumen preparata 30, Semen Juglandis 35, Fructus Jujubae 35, Mel 35, Cortex Cinnamomi 8, Semen Tritici aestivi 30, Crinis Carbonisatus 3, Radix Ginseng 10, Radix Angelicae Sinensis 10, Radix Polygoni Multiflori Preparata 10, the Rhizoma Atractylodis Macrocephalae 10, Ootheca Mantidis 20, Fructus Alpiniae Oxyphyllae 20, Rhizoma dioscoreae 20.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210176180XA CN102727806B (en) | 2012-05-31 | 2012-05-31 | Traditional Chinese medicine for treating aplastic anemia by tonifying qi |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210176180XA CN102727806B (en) | 2012-05-31 | 2012-05-31 | Traditional Chinese medicine for treating aplastic anemia by tonifying qi |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102727806A CN102727806A (en) | 2012-10-17 |
CN102727806B true CN102727806B (en) | 2013-11-20 |
Family
ID=46984570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210176180XA Expired - Fee Related CN102727806B (en) | 2012-05-31 | 2012-05-31 | Traditional Chinese medicine for treating aplastic anemia by tonifying qi |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102727806B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115770282A (en) * | 2022-12-13 | 2023-03-10 | 焦学军 | Pharmaceutical composition for treating aplastic anemia |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1233390C (en) * | 2003-10-30 | 2005-12-28 | 吉林省辽源亚东药业股份有限公司 | Chinese materia medica preparation of recreating blood for curing anaemia and producing method |
CN101204497A (en) * | 2007-12-19 | 2008-06-25 | 干慕美 | Peroral Chinese traditional medicine for aplastic anemia |
CN101391056B (en) * | 2008-10-23 | 2010-11-17 | 王湛 | Medicine for treating aplastic anemia |
CN102138943B (en) * | 2011-03-30 | 2014-03-12 | 冯金民 | Traditional Chinese medicinal preparation for treating anemia |
-
2012
- 2012-05-31 CN CN201210176180XA patent/CN102727806B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102727806A (en) | 2012-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103349753A (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
CN101780223B (en) | Traditional Chinese medicine with integral coordination function for treating ischemic cerebrovascular disease | |
CN101130054A (en) | Traditional Chinese medicine for treating phlegm-turbidity internal-resistance type dizziness | |
CN102698058B (en) | Health care extract for adjusting sub-healthy state of human body | |
CN101912596B (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
CN102727806B (en) | Traditional Chinese medicine for treating aplastic anemia by tonifying qi | |
CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
CN104771509A (en) | Traditional Chinese medicine composition for treating migraine | |
CN101564505B (en) | Chinese medicament for treating pulmonary heart disease | |
CN103800689A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
CN101843778B (en) | Chinese medicament for treating ichthyosis | |
CN102793845B (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
CN101537114B (en) | Chinese medicine for treating arrhythmia | |
CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor | |
CN102284023A (en) | Chinese medicinal composition for treating asthma | |
CN101843718B (en) | Chinese medicament for treating lupus erythematosus | |
CN102727765A (en) | Internally-used medicine for treating aplastic anemia by nourishing yin and yang | |
CN102406879A (en) | Chinese medicine composition for treating rhinitis | |
CN102727747B (en) | Medicine for treating aplastic anemia through detoxification | |
CN104587215A (en) | Traditional Chinese medicine composition for treating kidney yin deficiency | |
CN103751607A (en) | Traditional Chinese medicine composition for the treatment of aplastic anemia | |
CN101843722B (en) | Chinese medicament for treating ichthyosis | |
CN101843711B (en) | Chinese medicament for treating ichthyosis | |
CN101843771B (en) | Chinese medicament for treating ichthyosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131120 Termination date: 20140531 |